Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy | Clinical Trials | Clareo Health

Back to search

COMPLETEDNA

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

NCT03657849•HealthPartners Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Enlarged Lymph Nodes (Excluding Infective)

Interventions

EBUS TBNA

Locations

United States

Locations (1)

Regions Hospital

Saint Paul, Minnesota, United States

Key Dates

Start Date

July 18, 2018

Primary Completion Date

January 25, 2019

Completion Date

August 31, 2019

Last Updated

March 21, 2023

Sponsors

Lead Sponsor

HealthPartners Institute

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 21, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions